ICD-10 Coding for Pheochromocytoma(C74.1, C74.1M, C74.1N)
Comprehensive guide on ICD-10 coding for pheochromocytoma, including malignant and benign classifications, documentation requirements, and billing considerations.
Complete code families applicable to Pheochromocytoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C74.1 | Malignant neoplasm of adrenal medulla | Use when there is confirmed malignancy of the adrenal medulla. |
|
| D35.00 | Benign neoplasm of adrenal gland, unspecified | Use when the tumor is benign and confined to the adrenal gland. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutPheochromocytoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Pheochromocytoma.
Omitting secondary hypertension code
Impact
Clinical: Incomplete clinical picture of the patient's condition., Regulatory: Non-compliance with coding guidelines., Financial: Potential loss of reimbursement for related treatments.
Mitigation
Review patient history for hypertension, Ensure linkage to pheochromocytoma in documentation
Coding benign pheochromocytoma as malignant without confirmation
Impact
Reimbursement: Incorrect coding can lead to overpayment or claim denial., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Inaccurate clinical data affecting patient records.
Mitigation
Ensure pathology reports confirm malignancy before coding as C74.1.
Malignant vs. benign coding
Impact
Risk of misclassification affecting reimbursement and compliance.
Mitigation
Require pathology confirmation before coding malignancy.